cdk4 glutathione Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer Nuclear glutathione cycle and associated

Schutte R, Whincup PH, Papacosta O, Lennon LT, Macfarlane PW, Wannamethee G

6467 No significant differences in serum lead and selenium levels were observed between those with and without PHG

Depending on the specific phosphorylation site of the modification, Drp1 may exert either an activating or inhibitory effect on mitochondrial fission (Jin et al., 2021)

CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes

Studies show there is essentially no difference between these two procedures, except the possible cosmetic look with a tenotomy

In: Physiopathology of Endocrine Diseases and Mechanisms of Hormone Action